Literature DB >> 12919321

Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.

Heather M Knott1, Bronwyn E Brown, Michael J Davies, Roger T Dean.   

Abstract

Patients with diabetes mellitus suffer from an increased incidence of complications including cardiovascular disease and cataracts; the mechanisms responsible for this are not fully understood. One characteristic of such complications is an accumulation of advanced glycation end-products formed by the adduction of glucose or species derived from glucose, such as low-molecular mass aldehydes, to proteins. These reactions can be nonoxidative (glycation) or oxidative (glycoxidation) and result in the conversion of low-density lipoproteins (LDL) to a form that is recognized by the scavenger receptors of macrophages. This results in the accumulation of cholesterol and cholesteryl esters within macrophages and the formation of foam cells, a hallmark of atherosclerosis. The nature of the LDL modifications required for cellular recognition and unregulated uptake are poorly understood. We have therefore examined the nature, time course, and extent of LDL modifications induced by glucose and two aldehydes, methylglyoxal and glycolaldehyde. It has been shown that these agents modify Arg, Lys and Trp residues of the apoB protein of LDL, with the extent of modification induced by the two aldehydes being more rapid than with glucose. These processes are rapid and unaffected by low concentrations of copper ions. In contrast, lipid and protein oxidation are slow processes and occur to a limited extent in the absence of added copper ions. No evidence was obtained for the stimulation of lipid or protein oxidation by glucose or methylglyoxal in the presence of copper ions, whereas glycolaldehyde stimulated such reactions to a modest extent. These results suggest that the earliest significant events in this system are metal ion-independent glycation (modification) of the protein component of LDL, whilst oxidative events (glycoxidation or direct oxidation of lipid or proteins) only occur to any significant extent at later time points. This 'carbonyl-stress' may facilitate the formation of foam cells and the vascular complications of diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919321     DOI: 10.1046/j.1432-1033.2003.03742.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  15 in total

Review 1.  In-depth understanding of molecular mechanisms of aldehyde toxicity to engineer robust Saccharomyces cerevisiae.

Authors:  Lahiru N Jayakody; Yong-Su Jin
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-20       Impact factor: 4.813

2.  The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.

Authors:  E Nobecourt; M J Davies; B E Brown; L K Curtiss; D J Bonnet; F Charlton; A S Januszewski; A J Jenkins; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

Review 3.  Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View.

Authors:  Alice Biosa; Tiago F Outeiro; Luigi Bubacco; Marco Bisaglia
Journal:  Mol Neurobiol       Date:  2018-03-28       Impact factor: 5.590

4.  Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.

Authors:  B E Brown; R T Dean; M J Davies
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

5.  Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophages.

Authors:  J Graessler; J Pietzsch; T Westendorf; U Julius; S R Bornstein; S Kopprasch
Journal:  Diabetologia       Date:  2007-03-23       Impact factor: 10.122

6.  Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.

Authors:  E Nobécourt; J Zeng; M J Davies; B E Brown; S Yadav; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

7.  Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity.

Authors:  B Bartling; M Desole; R-E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

8.  Evaluation of the Relationship Between Bioactive Components in Seaweeds and Advanced Glycation End-Products Inhibitory Activities Using Principal Component Analysis.

Authors:  Chi Heung Cho; Ga Hee Youm; Mingyeong Kim; Sera Kim; Eun-Ji Song; Young-Do Nam; Sang-Hoon Lee
Journal:  Plant Foods Hum Nutr       Date:  2021-07-19       Impact factor: 3.921

9.  Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins.

Authors:  B E Brown; F M Mahroof; N L Cook; D M van Reyk; M J Davies
Journal:  Diabetologia       Date:  2006-02-08       Impact factor: 10.122

10.  Apolipoprotein A-I glycation by glucose and reactive aldehydes alters phospholipid affinity but not cholesterol export from lipid-laden macrophages.

Authors:  Bronwyn E Brown; Estelle Nobecourt; Jingmin Zeng; Alicia J Jenkins; Kerry-Anne Rye; Michael J Davies
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.